Off Patent
January 2027

Nevanac

nepafenac

Harrow Eye LLC

Suspension/drops (ophthalmic) · NDA 021862

Last listed protection ends
January 31, 2027

The FDA lists 1 patent for Nevanac, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,834,059
    Claims a use (U-1095)